These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 21822587

  • 1. Epitope mapping of human VWF A3 recognized by monoclonal antibody SZ-123 and SZ-125 using MALDI mass spectrometry.
    Jiang M, Zhao Y, Shen F, Wang F, He Y, Ruan C.
    Int J Hematol; 2011 Sep; 94(3):241-247. PubMed ID: 21822587
    [Abstract] [Full Text] [Related]

  • 2. [Identification of the epitope of von Willebrand factor recognized by monoclonal antibody SZ-125 with immune-affinity mass spectrometry].
    Li X, Wang F, Shen F, Zhao Y, Jiang M.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Mar; 29(3):284-6. PubMed ID: 23643086
    [Abstract] [Full Text] [Related]

  • 3. Two novel monoclonal antibodies to VWFA3 inhibit VWF-collagen and VWF-platelet interactions.
    Zhao Y, Dong N, Shen F, Xie L, He Y, Liu F, Ruan C.
    J Thromb Haemost; 2007 Sep; 5(9):1963-70. PubMed ID: 17723136
    [Abstract] [Full Text] [Related]

  • 4. A consensus tetrapeptide selected by phage display adopts the conformation of a dominant discontinuous epitope of a monoclonal anti-VWF antibody that inhibits the von Willebrand factor-collagen interaction.
    Vanhoorelbeke K, Depraetere H, Romijn RA, Huizinga EG, De Maeyer M, Deckmyn H.
    J Biol Chem; 2003 Sep 26; 278(39):37815-21. PubMed ID: 12855711
    [Abstract] [Full Text] [Related]

  • 5. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
    De Luca M, Facey DA, Favaloro EJ, Hertzberg MS, Whisstock JC, McNally T, Andrews RK, Berndt MC.
    Blood; 2000 Jan 01; 95(1):164-72. PubMed ID: 10607699
    [Abstract] [Full Text] [Related]

  • 6. Identification of novel peptide antagonists for von Willebrand factor binding to the platelet glycoprotein Ib receptor from a phage epitope library.
    South V, Searfoss GH, French S, Cheadle C, Murray E, Howk R, Jaye M, Ricca GA.
    Thromb Haemost; 1995 Jan 01; 73(1):144-50. PubMed ID: 7537918
    [Abstract] [Full Text] [Related]

  • 7. Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor.
    Matsushita T, Sadler JE.
    J Biol Chem; 1995 Jun 02; 270(22):13406-14. PubMed ID: 7539426
    [Abstract] [Full Text] [Related]

  • 8. [Characterization and functional studies of vWF A3 domain monoclonal antibodies that inhibit binding of vWF to collagen].
    Zhao YM, Dong NZ, Shen F, Xie LQ, Ruan CG.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar 02; 29(3):171-4. PubMed ID: 18788616
    [Abstract] [Full Text] [Related]

  • 9. The alpha1 helix-beta13 strand spanning Leu214 to Val229 of platelet glycoprotein Ibalpha facilitates the interaction with von Willebrand factor: evidence from characterization of the epitope of monoclonal antibody AP1.
    Peng Y, Berndt MC, Cruz MA, López JA.
    Blood; 2004 Dec 15; 104(13):3971-8. PubMed ID: 15319289
    [Abstract] [Full Text] [Related]

  • 10. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib.
    Obert B, Houllier A, Meyer D, Girma JP.
    Blood; 1999 Mar 15; 93(6):1959-68. PubMed ID: 10068669
    [Abstract] [Full Text] [Related]

  • 11. Anti-human VWF monoclonal antibody SZ-123 prevents arterial thrombus formation by inhibiting VWF-collagen and VWF-platelet interactions in Rhesus monkeys.
    Zhao YM, Jiang M, Ji SD, He Y, Shen F, Li XM, Ruan CG.
    Biochem Pharmacol; 2013 Apr 01; 85(7):945-53. PubMed ID: 23295157
    [Abstract] [Full Text] [Related]

  • 12. Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V.
    Ulrichts H, Udvardy M, Lenting PJ, Pareyn I, Vandeputte N, Vanhoorelbeke K, Deckmyn H.
    J Biol Chem; 2006 Feb 24; 281(8):4699-707. PubMed ID: 16373331
    [Abstract] [Full Text] [Related]

  • 13. Binding site on human von Willebrand factor of bitiscetin, a snake venom-derived platelet aggregation inducer.
    Matsui T, Hamako J, Matsushita T, Nakayama T, Fujimura Y, Titani K.
    Biochemistry; 2002 Jun 25; 41(25):7939-46. PubMed ID: 12069583
    [Abstract] [Full Text] [Related]

  • 14. Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis.
    Nakayama T, Matsushita T, Yamamoto K, Mutsuga N, Kojima T, Katsumi A, Nakao N, Sadler JE, Naoe T, Saito H.
    Int J Hematol; 2008 May 25; 87(4):363-370. PubMed ID: 18369690
    [Abstract] [Full Text] [Related]

  • 15. Anti-vWf antibodies induce GPIbalpha and FcgammaRII mediated platelet aggregation only at low shear forces.
    Hoylaerts MF, Viaene A, Thys C, Deckmyn H, Vermylen J.
    J Thromb Thrombolysis; 2001 Dec 25; 12(3):249-62. PubMed ID: 11981108
    [Abstract] [Full Text] [Related]

  • 16. Shielding the front-strand beta 3 of the von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibalpha.
    Bonnefoy A, Yamamoto H, Thys C, Kito M, Vermylen J, Hoylaerts MF.
    Blood; 2003 Feb 15; 101(4):1375-83. PubMed ID: 12393553
    [Abstract] [Full Text] [Related]

  • 17. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
    Girma JP, Takahashi Y, Yoshioka A, Diaz J, Meyer D.
    Thromb Haemost; 1990 Oct 22; 64(2):326-32. PubMed ID: 1702906
    [Abstract] [Full Text] [Related]

  • 18. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
    Tout H, Obert B, Houllier A, Fressinaud E, Rothschild C, Meyer D, Girma JP.
    Thromb Haemost; 2000 Feb 22; 83(2):274-81. PubMed ID: 10739386
    [Abstract] [Full Text] [Related]

  • 19. A monoclonal antibody (B724) to von Willebrand factor recognizing an epitope within the A1 disulphide loop (Cys509-Cys695) discriminates between type 2A and type 2B von Willebrand disease.
    Christophe O, Rouault C, Obert B, Piétu G, Meyer D, Girma JP.
    Br J Haematol; 1995 May 22; 90(1):195-203. PubMed ID: 7540413
    [Abstract] [Full Text] [Related]

  • 20. Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand factor by using recombinant cDNA libraries.
    Piétu G, Ribba AS, Chérel G, Siguret V, Obert B, Rouault C, Ginsburg D, Meyer D.
    Thromb Haemost; 1994 Jun 22; 71(6):788-92. PubMed ID: 7974349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.